--- title: "Rani Therapeutics Holdings Metrics Guide" description: "Rani Therapeutics Holdings Inc. revenue, margins, cash flow and balance sheet figures by fiscal year, taken from its SEC filings, with the ratios explained." canonical: https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/financial-metrics/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Rani Therapeutics Holdings Inc. Financial Metrics Guide ## Direct Answer > Rani Therapeutics Holdings Inc. reported revenue of $2 million for the fiscal year ended December 31, 2025, with an operating margin of -2346.0% and net income of -$30 million, according to its SEC filings. Revenue grew 58.9% from the prior year. ## What Are Rani Therapeutics Holdings Inc.'s Key Financial Figures? | Fiscal year | FY2025ended December 31, 2025 | FY2024ended December 31, 2024 | FY2023ended December 31, 2023 | FY2022ended December 31, 2022 | | --- | --- | --- | --- | --- | | Revenue | $2 million | $1 million | $0 | $0 | | Operating income | -$38 million | -$53 million | -$66 million | -$63 million | | Operating margin | -2346.0% | -5186.2% | n/a | n/a | | Net income | -$30 million | -$30 million | -$34 million | -$31 million | | Net margin | -1817.1% | -2920.0% | n/a | n/a | | Operating cash flow | -$19 million | -$35 million | -$51 million | -$47 million | | Capital expenditures | $88,000 | $268,000 | $1 million | $2 million | | Free cash flow | -$19 million | -$36 million | -$52 million | -$48 million | Operating margin widened by 2840.2 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was -$19 million against net income of -$30 million; cash generation covered reported earnings. ![Bar chart of Rani Therapeutics Holdings Inc. revenue, operating income, net income for fiscal 2022 to 2025. In fiscal 2025, revenue was $2 million, operating income negative $38 million and net income negative $30 million.](https://www.getswoopr.com/images/charts/rani-therapeutics-holdings-inc-metrics-revenue-profit.webp) *Rani Therapeutics Holdings Inc. revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.* ![Line chart of Rani Therapeutics Holdings Inc. operating margin and net margin for fiscal 2022 to 2025. In fiscal 2025, operating margin was -2346.0% and net margin was -1817.1%.](https://www.getswoopr.com/images/charts/rani-therapeutics-holdings-inc-metrics-margins.webp) *Rani Therapeutics Holdings Inc. operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.* ![Bar chart of Rani Therapeutics Holdings Inc. operating cash flow, capital expenditures, free cash flow for fiscal 2022 to 2025. In fiscal 2025, operating cash flow was negative $19 million, capital expenditures was $88,000, free cash flow was negative $19 million.](https://www.getswoopr.com/images/charts/rani-therapeutics-holdings-inc-metrics-cash-flow.webp) *Rani Therapeutics Holdings Inc. operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.* ## What Does Rani Therapeutics Holdings Inc.'s Balance Sheet Show? | Cash and cash equivalents | $19 million | | --- | --- | | Long-term debt | $0 | | Total assets | $59 million | | Total liabilities | $17 million | | Shareholders' equity | $33 million | | Current ratio | 4.2x | Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions. ## Where These Numbers Come From Every figure on this page is a value Rani Therapeutics Holdings Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001193125-26-126417 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### What was Rani Therapeutics Holdings Inc.'s revenue in fiscal 2025? Rani Therapeutics Holdings Inc. reported revenue of $2 million for the fiscal year ended December 31, 2025, according to its SEC filings. ### What is Rani Therapeutics Holdings Inc.'s operating margin? Rani Therapeutics Holdings Inc.'s operating margin was -2346.0% in fiscal 2025: operating income of -$38 million on revenue of $2 million. ### How much free cash flow did Rani Therapeutics Holdings Inc. generate? Operating cash flow of -$19 million less capital expenditures of $88,000 gives free cash flow of -$19 million for fiscal 2025. ## References - [SEC EDGAR: Rani Therapeutics Holdings, Inc. Form 10-K filed March 26, 2026](https://www.sec.gov/Archives/edgar/data/1856725/000119312526126417/rani-20251231.htm) - [SEC EDGAR: Rani Therapeutics Holdings, Inc. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1856725&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Rani Therapeutics Holdings Inc. company dossier](https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/) - [Rani Therapeutics Holdings Inc. financial metrics](https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/financial-metrics/) - [Rani Therapeutics Holdings Inc. financial risk indicators](https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/risks-monitoring/) - [Rani Therapeutics Holdings Inc. business model and revenue mix](https://www.getswoopr.com/stocks/companies/rani-therapeutics-holdings-inc/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) [Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/) Swoopr's editorial team produces independent investment education content. Content is for educational purposes only and does not constitute personalized investment advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).